down arrow

Aigan Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3101000002
  • TKS: 9854
JPY
273.00
-2 (-0.73%)

Sep 25

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Precision System Science Co., Ltd.
Kowa Co. Ltd. (Osaka)
Create Medic Co., Ltd.
Immuno-Biological Laboratories Co., Ltd.
3-D Matrix Ltd.
Sincere Co., Ltd. (Japan)
Shigematsu Works Co., Ltd.
Aigan Co., Ltd.
JMS Co., Ltd.
Koken Ltd.
Kawamoto Corp.

Why is Aigan Co., Ltd. ?

1
Poor Management Efficiency with a low ROE of 0.11%
  • The company has been able to generate a Return on Equity (avg) of 0.11% signifying low profitability per unit of shareholders funds
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -366.40
  • Poor long term growth as Net Sales has grown by an annual rate of 2.22% and Operating profit at 17.99% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -366.40
  • The company has been able to generate a Return on Equity (avg) of 0.11% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 2.22% and Operating profit at 17.99% over the last 5 years
4
The company declared positive results in Jun'26 after flat results in Mar'26
  • ROCE(HY) Highest at 2.92%
  • DEBT-EQUITY RATIO (HY) Lowest at -36.67 %
  • NET PROFIT(Q) At JPY 98 MM has Grown at 157.48%
5
With ROE of 2.25%, it has a very attractive valuation with a 0.38 Price to Book Value
  • Over the past year, while the stock has generated a return of 43.23%, its profits have risen by 269.6% ; the PEG ratio of the company is 0.1
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Aigan Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Aigan Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Aigan Co., Ltd.
32.52%
1.02
52.62%
Japan Nikkei 225
43.58%
1.48
29.43%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
2.22%
EBIT Growth (5y)
17.99%
EBIT to Interest (avg)
-217.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.36
Sales to Capital Employed (avg)
1.23
Tax Ratio
44.24%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.59%
ROE (avg)
0.11%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
0.38
EV to EBIT
2.89
EV to EBITDA
1.31
EV to Capital Employed
0.05
EV to Sales
0.03
PEG Ratio
0.06
Dividend Yield
0.45%
ROCE (Latest)
1.79%
ROE (Latest)
2.25%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
ROCE(HY)

Highest at 2.92%

DEBT-EQUITY RATIO (HY)

Lowest at -36.67 %

NET PROFIT(Q)

At JPY 98 MM has Grown at 157.48%

RAW MATERIAL COST(Y)

Fallen by -1.62% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 19.39 times

PRE-TAX PROFIT(Q)

At JPY 154 MM has Grown at 87.8%

-1What is not working for the Company
INVENTORY TURNOVER RATIO(HY)

Lowest at 1.94 times

Here's what is working for Aigan Co., Ltd.

Net Profit
At JPY 98 MM has Grown at 157.48%
over average net sales of the previous four periods of JPY 38.06 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (JPY MM)

Debt-Equity Ratio
Lowest at -36.67 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Pre-Tax Profit
At JPY 154 MM has Grown at 87.8%
over average net sales of the previous four periods of JPY 82 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

Debtors Turnover Ratio
Highest at 19.39 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -1.62% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Aigan Co., Ltd.

Inventory Turnover Ratio
Lowest at 1.94 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Footer loading